SEI INVESTMENTS CO - HAEMONETICS CORP MASS ownership

HAEMONETICS CORP MASS's ticker is and the CUSIP is 405024AB6. A total of 35 filers reported holding HAEMONETICS CORP MASS in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
SEI INVESTMENTS CO ownership history of HAEMONETICS CORP MASS
ValueSharesWeighting
Q3 2023$290,613
+2.0%
335,0000.0%0.00%
Q2 2023$285,051
+82.6%
335,000
+82.1%
0.00%
Q1 2023$156,121
+2.7%
184,0000.0%0.00%
Q4 2022$152,039
+4.1%
184,0000.0%0.00%
Q3 2022$146,000
+82.5%
184,000
+80.4%
0.00%
Q2 2022$80,000
-5.9%
102,0000.0%0.00%
Q1 2022$85,000102,0000.00%
Other shareholders
HAEMONETICS CORP MASS shareholders Q1 2022
NameSharesValueWeighting ↓
Wellesley Asset Management 33,106,000$28,184,1312.08%
OSTERWEIS CAPITAL MANAGEMENT INC 18,000,000$15,362,6921.04%
Kohlberg Kravis Roberts & Co. L.P. 39,055,000$33,332,7791.00%
ADVENT CAPITAL MANAGEMENT /DE/ 60,053,000$51,254,2150.97%
DeepCurrents Investment Group LLC 20,750,000$17,615,0920.69%
SSI INVESTMENT MANAGEMENT LLC 10,967,000$9,305,3140.65%
Quaero Capital S.A. 900,000$768,4200.56%
Aequim Alternative Investments LP 20,500,000$17,496,4020.56%
STEELHEAD PARTNERS LLC 9,500,000$8,087,6350.53%
MACKAY SHIELDS LLC 19,791,000$16,891,2800.46%
View complete list of HAEMONETICS CORP MASS shareholders